Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis

Gaitanidis, Apostolos; Patel, Dhaval; Nilubol, Naris; Tirosh, Amit; Sadowski Veuthey, Mercedes Samira Doris; Kebebew, Electron

doi:10.1245/s10434-017-6241-4

Scientific article

English

Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis

ContributorsGaitanidis, Apostolos; Patel, Dhaval; Nilubol, Naris; Tirosh, Amit; Sadowski Veuthey, Mercedes Samira Doris; Kebebew, Electron

Published inAnnals of Surgical Oncology, vol. 25, no. 1, p. 122-130

Publication date2018

Abstract

The prognosis and behavior of pancreatic neuroendocrine tumors (PNETs) vary and may be divergent even at the same stage or tumor grade. Markers of systemic inflammatory response are readily available and are inexpensive, and have been shown to be prognostic factors in several cancers.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de chirurgie

Research groups

Cancer du poumon et mésothéliome pleural malin (944)

Citation (ISO format)

GAITANIDIS, Apostolos et al. Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis. In: Annals of Surgical Oncology, 2018, vol. 25, n° 1, p. 122–130. doi: 10.1245/s10434-017-6241-4

Article (Published version)

Identifiers

PID : unige:100714
DOI : 10.1245/s10434-017-6241-4
PMID : 29134377

Journal ISSN1068-9265

501views

0downloads

Creation05/12/2017 10:41:00

First validation05/12/2017 10:41:00

Update15/03/2023 07:40:58

Status update15/03/2023 07:40:58

Last indexation31/10/2024 09:11:46

Archive ouverte UNIGE

Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis

The prognosis and behavior of pancreatic neuroendocrine tumors (PNETs) vary and may be divergent even at the same stage or tumor grade. Markers of systemic inflammatory response are readily available and are inexpensive, and have been shown to be prognostic factors in several cancers.

Technical informations